Feedback
AUROPHARMA 
Reputation: 642,681 • Jul 10, 2023 3:48 PM
Aurobindo Pharma arm enters into license agreement with US company; shares fall
Under the terms of the agreement, CuraTeQ has been granted exclusive license rights to commercialise BFI-751 in all major regulated markets, certain semi-regulated, and emerging markets worldwide.
Moneycontrol
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 728.5